相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
Albert Do et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C
Zobair M. Younossi et al.
LIVER INTERNATIONAL (2019)
Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update
Ru Han et al.
BMC INFECTIOUS DISEASES (2019)
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation
Yvonne Huber et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
Silvia Nardelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study
Lisa Strada et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2019)
Depression, fatigue and neurocognitive deficits in chronic hepatitis C
Sern Wei Yeoh et al.
HEPATOLOGY INTERNATIONAL (2018)
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases
Amare Aregay et al.
LIVER INTERNATIONAL (2018)
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
Benedikt Strunz et al.
NATURE COMMUNICATIONS (2018)
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals
Sahar Saeed et al.
JOURNAL OF VIRAL HEPATITIS (2018)
The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study
Patricia A. M. Kracht et al.
INFECTIOUS DISEASES AND THERAPY (2018)
Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?!
M. Dirks et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Hepatitis C virus infection, and neurological and psychiatric disorders - A review
Lydia Yarlott et al.
JOURNAL OF ADVANCED RESEARCH (2017)
A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life
R. L. Kolotkin et al.
CLINICAL OBESITY (2017)
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
Annette Bruchfeld et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Current therapy for chronic hepatitis C: The role of direct-acting antivirals
Guangdi Li et al.
ANTIVIRAL RESEARCH (2017)
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
Sahar Saeed et al.
CLINICAL INFECTIOUS DISEASES (2016)
Reversion of disease manifestations after HCV eradication
Adriaan J. van der Meer et al.
JOURNAL OF HEPATOLOGY (2016)
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C
Julia Hengst et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus
Z. M. Younossi et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Systemic manifestations of hepatitis C infection
Lydia Tang et al.
INFECTIOUS AGENTS AND CANCER (2016)
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2015)
Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection
Marilyn Huckans et al.
BRAIN AND BEHAVIOR (2014)
Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
M. Vera-Llonch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
Health-Related Quality of Life Among Older Adults With and Without Functional Limitations
William W. Thompson et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2012)
Natural history of acute and chronic hepatitis C
Benjamin Maasoumy et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Measuring substantial reductions in functioning in patients with chronic fatigue syndrome
Leonard Jason et al.
DISABILITY AND REHABILITATION (2011)
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
Elisa Fabbrini et al.
HEPATOLOGY (2010)
Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease
G. Coteur et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
Einar Bjornsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Meta-analysis of depression and substance use among individuals with alcohol use disorders
Kenneth R. Conner et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Health-related quality of life in patients with non-alcoholic fatty liver disease
A. A. Dan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Herbert L. Bonkovsky et al.
JOURNAL OF HEPATOLOGY (2007)
The many faces of fatigue in major depressive disorder
K Demyttenaere et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
A model to predict survival in patients with end-stage liver disease
PS Kamath et al.
HEPATOLOGY (2001)
Factors associated with poor health-related quality of life of patients with cirrhosis
G Marchesini et al.
GASTROENTEROLOGY (2001)
Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
MR Kraus et al.
PSYCHOSOMATICS (2000)
分享论文
